相关实验视频
Updated: Sep 15, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
血红蛋白糖化指数与心脏代谢疾病之间的关联:一篇小小的评论
Qing-Yun Wu1,2, Li-Rong Mo1, Jing Nan3
1Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
血红蛋白糖化指数 (HGI) 提供了比HbA1c更好的长期血糖控制评估. 升高的HGI与心脏代谢疾病有关,有助于临床风险预测.
科学领域:
- 内分泌学和新陈代谢学
- 心血管医学 心血管医学
- 临床生物化学 临床生物化学
背景情况:
- 血红蛋白糖化指数 (HGI) 是长期血糖控制的生物标志物.
- HGI提供了比糖化血红蛋白 (HbA1c) 更全面的评估.
- 升高的HGI与心脏代谢性疾病 (CMD) 相相关.
研究的目的:
- 审查HGI在各种心脏代谢疾病中的临床实用性.
- 为临床医生提供疾病分层和管理的增强框架.
- 探索HGI在冠状动脉疾病,高血压,心力衰竭,糖尿病,血清尿酸水平和非酒精性脂肪肝疾病中的作用.
主要方法:
- 对HGI当前证据的系统审查.
- 综合评估HGI与CMD相关的研究.
- 对HGI的预后和治疗影响的分析.
主要成果:
- HGI是心脏代谢疾病发病率的重要预测因素.
- 证据支持HGI在各种疾病中的实用性,包括CAD,HF,DM和NAFLD.
- HGI有助于精确的疾病分层和治疗优化.
结论:
- HGI是评估长期血糖控制和CMD风险的有价值生物标志物.
- 将HGI整合到临床实践中可以提高患者的管理和预后.
- 进一步研究HGI的应用是有必要的.
更多相关视频
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
相关概念视频
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Diabetes: Symptoms, Diagnosis, and Complications
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Proteoglycans